⌘K

Home/Filings/4/0000899243-17-016392

4//SEC Filing

HISTOGENICS CORP 4

Accession 0000899243-17-016392

$OCGNCIK 0001372299operating

View on SEC.gov Company Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 5:00 PM ET

Size

5.3 KB

Accession

0000899243-17-016392

Insider Transaction Report

Form 4

Period: 2017-06-13

HISTOGENICS CORPHSGX

Baltzell Joshua J

Director

Transactions

Award
Stock Option (Right to Buy)
2017-06-13+25,000→ 25,000 total
Exercise: $1.70Exp: 2027-06-12→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]This option vests and becomes exercisable with respect to 8.33% of the option shares for each one-month period following June 13, 2017.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

HISTOGENICS CORP

CIK 0001372299

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001372299

Filing Metadata

Form type: 4
Filed: Jun 13, 8:00 PM ET
Accepted: Jun 14, 5:00 PM ET
Size: 5.3 KB

View on SEC.gov